speb/financial-data huggingface dataset:
CPT cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: 114474000.00
CPT cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -226048000.00
CPT cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -226048000.00
CPT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -125395000.00
CPT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 1525000.00
CPT cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -5969000.00
CPT cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
CPT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 4675198000.00
CPT income_statement (annual, 2024-12-31) — Normalized EBITDA: 883698000.00
CPT income_statement (annual, 2024-12-31) — Normalized Income: 161427943.08
CPT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 774877000.00
CPT cash_flow (annual, 2024-12-31) — Operating Gains Losses: -42885000.00
CPT cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 0.00
CPT income_statement (annual, 2024-12-31) — Operating Income: 297264000.00
CPT income_statement (annual, 2024-12-31) — Operating Revenue: 1543842000.00
CPT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 106688152.00
CPT balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 974000.00
CPT income_statement (annual, 2024-12-31) — Other Gand A: 72365000.00
CPT income_statement (annual, 2024-12-31) — Other Income Expense: 1897000.00
CPT balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 234838000.00
CPT balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 212107000.00
CPT income_statement (annual, 2024-12-31) — Other Operating Expenses: -7137000.00
CPT income_statement (annual, 2024-12-31) — Other Special Charges: 921000.00
CPT income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
CPT income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 295000.00
CPT balance_sheet (annual, 2024-12-31) — Payables: 407257000.00
CPT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 407257000.00
CPT income_statement (annual, 2024-12-31) — Pretax Income: 173766000.00
CPT cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: 0.00
CPT balance_sheet (annual, 2024-12-31) — Receivables: 8991000.00
CPT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 599336000.00
CPT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 582014000.00
CPT cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1208000000.00
CPT cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -49997000.00
CPT balance_sheet (annual, 2024-12-31) — Restricted Cash: 11164000.00
CPT income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CPT balance_sheet (annual, 2024-12-31) — Retained Earnings: -897931000.00
CPT cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 114474000.00
CPT cash_flow (quarterly, 2024-12-31) — Sale Of Investment Properties: 0.00
CPT income_statement (annual, 2024-12-31) — Selling General And Administration: 72365000.00
CPT balance_sheet (annual, 2024-12-31) — Share Issued: 117737740.00
CPT cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
CPT income_statement (annual, 2024-12-31) — Special Income Charges: -41909000.00
CPT income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CPT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 15166000.00
CPT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 4675198000.00
CPT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 4675198000.00
CPT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 31943.08
CPT income_statement (annual, 2024-12-31) — Tax Provision: 2926000.00
CPT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.02
CPT balance_sheet (annual, 2024-12-31) — Total Assets: 8852144000.00
CPT balance_sheet (annual, 2024-12-31) — Total Capitalization: 8160789000.00
CPT balance_sheet (annual, 2024-12-31) — Total Debt: 3485591000.00
CPT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 4747189000.00
CPT income_statement (annual, 2024-12-31) — Total Expenses: 1246578000.00
CPT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 4104955000.00
CPT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 8810944000.00
CPT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3697698000.00
CPT balance_sheet (annual, 2024-12-31) — Total Tax Payable: 78529000.00
CPT income_statement (annual, 2024-12-31) — Total Unusual Items: 1897000.00
CPT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 1897000.00
CPT balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 11049588.00
CPT balance_sheet (annual, 2024-12-31) — Treasury Stock: 359732000.00
CPT balance_sheet (annual, 2024-12-31) — Working Capital: -366057000.00
CPT income_statement (quarterly, 2025-03-31) — +Operating Expense: 163713000.00
CPT income_statement (quarterly, 2025-03-31) — +Total Revenue: 390565000.00
CPT balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 195197000.00
CPT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 8950000.00
CPT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 5936982000.00
CPT income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 0.00
CPT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 108530000.00
CPT income_statement (quarterly, 2025-03-31) — Basic EPS: 0.36
CPT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 32209000.00
CPT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -78397000.00
CPT cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -78397000.00
CPT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1157000.00
CPT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 26182000.00
CPT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 26182000.00
CPT cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -113537000.00
CPT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 133309000.00
CPT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -275945000.00
CPT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 148216000.00
CPT cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -16003000.00
CPT cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: -32618000.00
CPT cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 179000.00
CPT cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 1697000.00
CPT cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 884000.00
CPT cash_flow (quarterly, 2025-03-31) — Change In Payable: -48621000.00
CPT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -48621000.00
CPT cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: -32618000.00
CPT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -45861000.00
CPT cash_flow (quarterly, 2025-03-31) — Changes In Cash: 5580000.00
CPT balance_sheet (quarterly, 2025-03-31) — Common Stock: 1157000.00
CPT cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -113537000.00
CPT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 4614956000.00
CPT cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CPT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 149986000.00
CPT balance_sheet (quarterly, 2025-03-31) — Current Assets: 46739000.00
CPT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 357372000.00
CPT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 149252000.00
CPT income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 149252000.00
CPT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 149252000.00
CPT income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 149252000.00
CPT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 108597000.00
CPT income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.36
CPT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 38731000.00
CPT balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 115983000.00
CPT income_statement (quarterly, 2025-03-31) — EBIT: 75116000.00
CPT income_statement (quarterly, 2025-03-31) — EBITDA: 224368000.00
CPT cash_flow (quarterly, 2025-03-31) — End Cash Position: 37789000.00
CPT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 133309000.00
CPT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 69819000.00
CPT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1325000.00
CPT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 16948000.00
CPT income_statement (quarterly, 2025-03-31) — Gross Profit: 240579000.00
CPT income_statement (quarterly, 2025-03-31) — Interest Expense: 33790000.00
CPT income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 33790000.00
CPT income_statement (quarterly, 2025-03-31) — Interest Income: 10000.00
CPT income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 10000.00
CPT cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 25415000.00
CPT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 8350627000.00
CPT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -275945000.00
CPT balance_sheet (quarterly, 2025-03-31) — Investment Properties: 8706394000.00
CPT cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 546000000.00
CPT balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 3735671000.00
CPT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3735671000.00
CPT cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 546000000.00
CPT cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -724000000.00
CPT balance_sheet (quarterly, 2025-03-31) — Minority Interest: 72262000.00
CPT income_statement (quarterly, 2025-03-31) — Minority Interests: -1945000.00
CPT cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CPT balance_sheet (quarterly, 2025-03-31) — Net Debt: 3709489000.00
CPT income_statement (quarterly, 2025-03-31) — Net Income: 38822000.00
CPT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 38731000.00
CPT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 40767000.00
CPT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 38822000.00
CPT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 38822000.00
CPT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 40767000.00
CPT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 40767000.00
CPT income_statement (quarterly, 2025-03-31) — Net Interest Income: -33780000.00
CPT cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: -196355000.00
CPT cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 247780000.00
CPT cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -178000000.00
CPT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -33780000.00
CPT cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -934000.00
CPT cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -1193000.00
CPT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
CPT cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 425780000.00
CPT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 4614956000.00
CPT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 224368000.00
CPT income_statement (quarterly, 2025-03-31) — Normalized Income: 38822000.00
CPT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 148216000.00
CPT income_statement (quarterly, 2025-03-31) — Operating Income: 76866000.00
CPT income_statement (quarterly, 2025-03-31) — Operating Revenue: 390565000.00
CPT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 106824141.00
CPT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 1325000.00
CPT income_statement (quarterly, 2025-03-31) — Other Gand A: 16948000.00
CPT income_statement (quarterly, 2025-03-31) — Other Income Expense: -1760000.00
CPT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 239999000.00
CPT balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 212871000.00
CPT income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -1760000.00
CPT income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -2487000.00
CPT income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 91000.00
CPT balance_sheet (quarterly, 2025-03-31) — Payables: 357372000.00
CPT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 357372000.00
CPT income_statement (quarterly, 2025-03-31) — Pretax Income: 41326000.00
CPT cash_flow (quarterly, 2025-03-31) — Purchase Of Investment Properties: -196355000.00
CPT balance_sheet (quarterly, 2025-03-31) — Receivables: 8950000.00
CPT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 149986000.00
CPT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 149252000.00
CPT cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -724000000.00
CPT cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CPT balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 11607000.00
CPT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -973416000.00
CPT cash_flow (quarterly, 2025-03-31) — Sale Of Investment Properties: 0.00
CPT cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
CPT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 16948000.00
CPT balance_sheet (quarterly, 2025-03-31) — Share Issued: 117737743.00
CPT cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 425780000.00
CPT income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
CPT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 4058000.00
CPT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 4614956000.00
CPT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4614956000.00
CPT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CPT income_statement (quarterly, 2025-03-31) — Tax Provision: 559000.00
CPT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.01
CPT balance_sheet (quarterly, 2025-03-31) — Total Assets: 8993132000.00
CPT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 8350627000.00
CPT balance_sheet (quarterly, 2025-03-31) — Total Debt: 3735671000.00
CPT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 4687218000.00
CPT income_statement (quarterly, 2025-03-31) — Total Expenses: 313699000.00
CPT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4305914000.00
CPT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 8946393000.00
CPT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3948542000.00
CPT balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 46192000.00
CPT income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
CPT income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CPT balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 10913602.00
CPT balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 351092000.00
CPT balance_sheet (quarterly, 2025-03-31) — Working Capital: -310633000.00
CPT income_statement (quarterly, 2025-06-30) — +Operating Expense: 170658000.00
CPT income_statement (quarterly, 2025-06-30) — +Total Revenue: 396509000.00
CPT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 206018000.00
CPT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 8889000.00
CPT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 5941893000.00
CPT income_statement (quarterly, 2025-06-30) — Average Dilution Earnings: 537000.00
CPT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 108636000.00
CPT income_statement (quarterly, 2025-06-30) — Basic EPS: 0.74
CPT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 37789000.00
CPT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -116820000.00
CPT cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -116820000.00
CPT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1157000.00
CPT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 33091000.00
CPT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 33091000.00
CPT cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -115953000.00
CPT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -26395000.00
CPT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -197512000.00
CPT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 230663000.00
CPT cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 6049000.00
CPT cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: 45580000.00
CPT cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -15558000.00
CPT cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 1326000.00
CPT cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 1670000.00
CPT cash_flow (quarterly, 2025-06-30) — Change In Payable: 51629000.00
CPT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 51629000.00
CPT cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: 45580000.00
CPT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 39067000.00
CPT cash_flow (quarterly, 2025-06-30) — Changes In Cash: 6756000.00
CPT balance_sheet (quarterly, 2025-06-30) — Commercial Paper: 515600000.00
CPT balance_sheet (quarterly, 2025-06-30) — Common Stock: 1157000.00
CPT cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -115953000.00
CPT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 4587485000.00
CPT cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
CPT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 154012000.00
CPT balance_sheet (quarterly, 2025-06-30) — Current Assets: 53434000.00
CPT balance_sheet (quarterly, 2025-06-30) — Current Debt: 515600000.00
CPT balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 515600000.00
CPT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 929579000.00
CPT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 152108000.00
CPT income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 152108000.00
CPT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 152108000.00
CPT income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 152108000.00
CPT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 109400000.00
CPT income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.74
CPT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 81034000.00
CPT balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 116007000.00
CPT income_statement (quarterly, 2025-06-30) — EBIT: 119200000.00
CPT income_statement (quarterly, 2025-06-30) — EBITDA: 271308000.00
CPT cash_flow (quarterly, 2025-06-30) — End Cash Position: 44545000.00
CPT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -26395000.00
CPT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 113843000.00
CPT income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 47293000.00
CPT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1676000.00
CPT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 21183000.00
CPT income_statement (quarterly, 2025-06-30) — Gross Profit: 242497000.00
CPT income_statement (quarterly, 2025-06-30) — Interest Expense: 35375000.00
CPT income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 35375000.00
CPT income_statement (quarterly, 2025-06-30) — Interest Income: 68000.00
CPT income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 68000.00
CPT cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 44915000.00
CPT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 8413461000.00
CPT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -197512000.00
CPT balance_sheet (quarterly, 2025-06-30) — Investment Properties: 8804039000.00
CPT cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 556821000.00
CPT balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 0.00
CPT balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 3310376000.00
CPT balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 3310376000.00
CPT cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 42000000.00
CPT cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -42000000.00
CPT balance_sheet (quarterly, 2025-06-30) — Minority Interest: 72511000.00
CPT income_statement (quarterly, 2025-06-30) — Minority Interests: -1924000.00
CPT cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CPT balance_sheet (quarterly, 2025-06-30) — Net Debt: 3792885000.00
CPT income_statement (quarterly, 2025-06-30) — Net Income: 80670000.00
CPT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 80497000.00
CPT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 82594000.00
CPT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 80670000.00
CPT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 80670000.00
CPT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 82594000.00
CPT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 82594000.00
CPT income_statement (quarterly, 2025-06-30) — Net Interest Income: -35307000.00
CPT cash_flow (quarterly, 2025-06-30) — Net Investment Properties Purchase And Sale: -79086000.00
CPT cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 89041000.00
CPT cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
CPT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -35307000.00
CPT cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 517000.00
CPT cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -1606000.00
CPT cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 89041000.00
CPT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 4587485000.00
CPT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 224015000.00
CPT income_statement (quarterly, 2025-06-30) — Normalized Income: 34071514.56
CPT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 230663000.00
CPT income_statement (quarterly, 2025-06-30) — Operating Income: 71839000.00
CPT income_statement (quarterly, 2025-06-30) — Operating Revenue: 396509000.00
CPT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 106852876.00
CPT balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1676000.00
CPT income_statement (quarterly, 2025-06-30) — Other Gand A: 21183000.00
CPT income_statement (quarterly, 2025-06-30) — Other Income Expense: 47293000.00
CPT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 262100000.00
CPT balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 219622000.00
CPT income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -2633000.00
CPT income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 173000.00
CPT balance_sheet (quarterly, 2025-06-30) — Payables: 413979000.00
CPT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 413979000.00
CPT income_statement (quarterly, 2025-06-30) — Pretax Income: 83825000.00
CPT cash_flow (quarterly, 2025-06-30) — Purchase Of Investment Properties: -137861000.00
CPT balance_sheet (quarterly, 2025-06-30) — Receivables: 8889000.00
CPT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 154012000.00
CPT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 152108000.00
CPT cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -42000000.00
CPT cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CPT balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 11454000.00
CPT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1007075000.00
CPT cash_flow (quarterly, 2025-06-30) — Sale Of Investment Properties: 58775000.00
CPT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 21183000.00
CPT balance_sheet (quarterly, 2025-06-30) — Share Issued: 117737746.00
CPT cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 89041000.00
CPT income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CPT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 4187000.00
CPT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 4587485000.00
CPT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 4587485000.00
CPT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 694514.56
CPT income_statement (quarterly, 2025-06-30) — Tax Provision: 1231000.00
CPT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.01
CPT balance_sheet (quarterly, 2025-06-30) — Total Assets: 9119573000.00
CPT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 7897861000.00
CPT balance_sheet (quarterly, 2025-06-30) — Total Debt: 3825976000.00
CPT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 4659996000.00
CPT income_statement (quarterly, 2025-06-30) — Total Expenses: 324670000.00
CPT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4459577000.00
CPT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 9066139000.00
CPT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 3529998000.00
CPT balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 91954000.00
CPT income_statement (quarterly, 2025-06-30) — Total Unusual Items: 47293000.00
CPT income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 47293000.00
CPT balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 10884870.00
CPT balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 350166000.00
CPT balance_sheet (quarterly, 2025-06-30) — Working Capital: -876145000.00
CPT income_statement (quarterly, 2025-09-30) — +Operating Expense: 176521000.00
CPT income_statement (quarterly, 2025-09-30) — +Total Revenue: 395676000.00
CPT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 232960000.00
CPT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 8889000.00
CPT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 5945277000.00
CPT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 108524000.00
CPT income_statement (quarterly, 2025-09-30) — Basic EPS: 1.00
CPT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 44545000.00
CPT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -115171000.00
CPT cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -115171000.00
CPT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1157000.00
CPT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 25931000.00
CPT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 25931000.00
CPT cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -115975000.00
CPT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -253055000.00
CPT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -5108000.00
CPT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 250927000.00
CPT cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 17193000.00
CPT cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 39127000.00
CPT cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -2663000.00
CPT cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 3947000.00
CPT cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 1444000.00
CPT cash_flow (quarterly, 2025-09-30) — Change In Payable: 56320000.00
CPT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 56320000.00
CPT cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 39127000.00
CPT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 59048000.00
CPT cash_flow (quarterly, 2025-09-30) — Changes In Cash: -7236000.00
CPT balance_sheet (quarterly, 2025-09-30) — Commercial Paper: 429600000.00
CPT balance_sheet (quarterly, 2025-09-30) — Common Stock: 1157000.00
CPT cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -115975000.00
CPT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4536293000.00
CPT cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -49999000.00
CPT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 155524000.00
CPT balance_sheet (quarterly, 2025-09-30) — Current Assets: 46198000.00
CPT balance_sheet (quarterly, 2025-09-30) — Current Debt: 429600000.00
CPT balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 429600000.00
CPT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 907775000.00
CPT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 159474000.00
CPT income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 159474000.00
CPT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 159474000.00
CPT income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 159474000.00
CPT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 108580000.00
CPT income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.00
CPT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 108701000.00
CPT balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 115518000.00
CPT income_statement (quarterly, 2025-09-30) — EBIT: 149354000.00
CPT income_statement (quarterly, 2025-09-30) — EBITDA: 308828000.00
CPT cash_flow (quarterly, 2025-09-30) — End Cash Position: 37309000.00
CPT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -253055000.00
CPT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 135756000.00
CPT cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -85645000.00
CPT income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 85645000.00
CPT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 2027000.00
CPT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 19612000.00
CPT income_statement (quarterly, 2025-09-30) — Gross Profit: 240152000.00
CPT income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
CPT cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 591000.00
CPT income_statement (quarterly, 2025-09-30) — Interest Expense: 34995000.00
CPT income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 34995000.00
CPT income_statement (quarterly, 2025-09-30) — Interest Income: 78000.00
CPT income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 78000.00
CPT cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 25600000.00
CPT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 8276529000.00
CPT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -5108000.00
CPT balance_sheet (quarterly, 2025-09-30) — Investment Properties: 8753635000.00
CPT cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: -86548000.00
CPT balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 0.00
CPT balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 3310636000.00
CPT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 3310636000.00
CPT cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
CPT cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
CPT balance_sheet (quarterly, 2025-09-30) — Minority Interest: 75482000.00
CPT income_statement (quarterly, 2025-09-30) — Minority Interests: -4645000.00
CPT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -49999000.00
CPT balance_sheet (quarterly, 2025-09-30) — Net Debt: 3714305000.00
CPT income_statement (quarterly, 2025-09-30) — Net Income: 108934000.00
CPT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 108701000.00
CPT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 113579000.00
CPT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 108934000.00
CPT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 108934000.00
CPT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 113579000.00
CPT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 113579000.00
CPT income_statement (quarterly, 2025-09-30) — Net Interest Income: -34917000.00
CPT cash_flow (quarterly, 2025-09-30) — Net Investment Properties Purchase And Sale: 110633000.00
CPT cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -86548000.00
CPT cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
CPT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -34917000.00
CPT cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -533000.00
CPT cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -570000.00
CPT cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -86548000.00
CPT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4536293000.00
CPT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 223183000.00
CPT income_statement (quarterly, 2025-09-30) — Normalized Income: 23873152.54
CPT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 250927000.00
CPT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -85645000.00
CPT income_statement (quarterly, 2025-09-30) — Operating Income: 63631000.00
CPT income_statement (quarterly, 2025-09-30) — Operating Revenue: 395676000.00
CPT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 106395571.00
CPT balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 2027000.00
CPT income_statement (quarterly, 2025-09-30) — Other Gand A: 19612000.00
CPT income_statement (quarterly, 2025-09-30) — Other Income Expense: 85645000.00
CPT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 255333000.00
CPT balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 224980000.00
CPT income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -2565000.00
CPT income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 233000.00
CPT balance_sheet (quarterly, 2025-09-30) — Payables: 478175000.00
CPT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 478175000.00
CPT income_statement (quarterly, 2025-09-30) — Pretax Income: 114359000.00
CPT cash_flow (quarterly, 2025-09-30) — Purchase Of Investment Properties: 0.00
CPT balance_sheet (quarterly, 2025-09-30) — Receivables: 8889000.00
CPT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 155524000.00
CPT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 159474000.00
CPT cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
CPT cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -49999000.00
CPT balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 11378000.00
CPT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1011983000.00
CPT cash_flow (quarterly, 2025-09-30) — Sale Of Investment Properties: 110633000.00
CPT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 19612000.00
CPT balance_sheet (quarterly, 2025-09-30) — Share Issued: 117737753.00
CPT cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: -86548000.00
CPT income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CPT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 4471000.00
CPT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4536293000.00
CPT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4536293000.00
CPT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 584152.54
CPT income_statement (quarterly, 2025-09-30) — Tax Provision: 780000.00
CPT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.01
CPT balance_sheet (quarterly, 2025-09-30) — Total Assets: 9055166000.00
CPT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 7846929000.00
CPT balance_sheet (quarterly, 2025-09-30) — Total Debt: 3740236000.00
CPT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4611775000.00
CPT income_statement (quarterly, 2025-09-30) — Total Expenses: 332045000.00
CPT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4443391000.00
CPT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 9008968000.00
CPT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3535616000.00
CPT balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 129697000.00
CPT income_statement (quarterly, 2025-09-30) — Total Unusual Items: 85645000.00
CPT income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 85645000.00
CPT balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 11342182.00
CPT balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 400185000.00
CPT balance_sheet (quarterly, 2025-09-30) — Working Capital: -861577000.00
CPT income_statement (annual, 2025-12-31) — +Operating Expense: 677402000.00
CPT income_statement (quarterly, 2025-12-31) — +Operating Expense: 164750000.00
CPT income_statement (annual, 2025-12-31) — +Total Revenue: 1573544000.00
CPT income_statement (quarterly, 2025-12-31) — +Total Revenue: 390794000.00
CPT balance_sheet (annual, 2025-12-31) — Accounts Payable: 248087000.00
CPT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 248087000.00
CPT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 8884000.00
CPT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 8884000.00
CPT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 5948938000.00
CPT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 5948938000.00
CPT cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 12916000.00
CPT cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 12916000.00
CPT income_statement (annual, 2025-12-31) — Average Dilution Earnings: 0.00
CPT income_statement (annual, 2025-12-31) — Basic Average Shares: 108376000.00
CPT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 107821000.00
CPT income_statement (annual, 2025-12-31) — Basic EPS: 3.54
CPT income_statement (quarterly, 2025-12-31) — Basic EPS: 1.44
CPT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 32209000.00
CPT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 37309000.00
CPT cash_flow (annual, 2025-12-31) — Capital Expenditure: -440402000.00
CPT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -130014000.00
CPT cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -440402000.00
CPT cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -130014000.00
CPT balance_sheet (annual, 2025-12-31) — Capital Stock: 1157000.00
CPT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1157000.00
CPT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 25203000.00
CPT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 25203000.00
CPT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 25203000.00
CPT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 25203000.00
CPT cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -460950000.00
CPT cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -115485000.00
CPT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -322049000.00
CPT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -175908000.00
CPT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -499539000.00
CPT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -20974000.00
CPT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 826621000.00
CPT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 196815000.00
CPT cash_flow (annual, 2025-12-31) — Change In Account Payable: 18293000.00
CPT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 11054000.00
CPT cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 17646000.00
CPT cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: -34443000.00
CPT cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 3449000.00
CPT cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 21491000.00
CPT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 6879000.00
CPT cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -91000.00
CPT cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 5466000.00
CPT cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 1468000.00
CPT cash_flow (annual, 2025-12-31) — Change In Payable: 35939000.00
CPT cash_flow (quarterly, 2025-12-31) — Change In Payable: -23389000.00
CPT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 35939000.00
CPT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -23389000.00
CPT cash_flow (annual, 2025-12-31) — Change In Tax Payable: 17646000.00
CPT cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: -34443000.00
CPT cash_flow (annual, 2025-12-31) — Change In Working Capital: 51733000.00
CPT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -521000.00
CPT cash_flow (annual, 2025-12-31) — Changes In Cash: 5033000.00
CPT cash_flow (quarterly, 2025-12-31) — Changes In Cash: -67000.00
CPT balance_sheet (annual, 2025-12-31) — Common Stock: 1157000.00
CPT balance_sheet (quarterly, 2025-12-31) — Common Stock: 1157000.00
CPT cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -460950000.00
CPT cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -115485000.00
CPT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 4362523000.00
CPT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 4362523000.00
CPT cash_flow (annual, 2025-12-31) — Common Stock Payments: -270654000.00
CPT cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -220655000.00
CPT income_statement (annual, 2025-12-31) — Cost Of Revenue: 607236000.00
CPT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 147714000.00
CPT balance_sheet (annual, 2025-12-31) — Current Assets: 46126000.00
CPT balance_sheet (quarterly, 2025-12-31) — Current Assets: 46126000.00
CPT balance_sheet (annual, 2025-12-31) — Current Liabilities: 455440000.00
CPT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 455440000.00
CPT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 611025000.00
CPT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 150191000.00
CPT income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 611025000.00
CPT income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 150191000.00
CPT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 611025000.00
CPT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 150191000.00
CPT income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 611025000.00
CPT income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 150191000.00
CPT income_statement (annual, 2025-12-31) — Diluted Average Shares: 108434000.00
CPT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 108617000.00
CPT income_statement (annual, 2025-12-31) — Diluted EPS: 3.54
CPT income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.44
CPT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 383638000.00
CPT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 155701000.00
CPT balance_sheet (annual, 2025-12-31) — Dividends Payable: 114971000.00
CPT balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 114971000.00
CPT income_statement (annual, 2025-12-31) — EBIT: 537156000.00
CPT income_statement (quarterly, 2025-12-31) — EBIT: 193486000.00
CPT income_statement (annual, 2025-12-31) — EBITDA: 1148181000.00
CPT income_statement (quarterly, 2025-12-31) — EBITDA: 343677000.00
CPT cash_flow (annual, 2025-12-31) — End Cash Position: 37242000.00
CPT cash_flow (quarterly, 2025-12-31) — End Cash Position: 37242000.00
CPT cash_flow (annual, 2025-12-31) — Financing Cash Flow: -322049000.00
CPT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -175908000.00
CPT cash_flow (annual, 2025-12-31) — Free Cash Flow: 386219000.00
CPT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 66801000.00
CPT cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -260910000.00
CPT cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -127972000.00
CPT income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 260910000.00
CPT income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 127972000.00
CPT balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2165000.00
CPT balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2165000.00
CPT income_statement (annual, 2025-12-31) — General And Administrative Expense: 79344000.00
CPT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 19841000.00
CPT income_statement (annual, 2025-12-31) — Gross Profit: 966308000.00
CPT income_statement (quarterly, 2025-12-31) — Gross Profit: 243080000.00
CPT income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 12916000.00
CPT income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 12916000.00
CPT cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 3482000.00
CPT cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 360000.00
CPT income_statement (annual, 2025-12-31) — Interest Expense: 138239000.00
CPT income_statement (quarterly, 2025-12-31) — Interest Expense: 34079000.00
CPT income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 138239000.00
CPT income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 34079000.00
CPT income_statement (annual, 2025-12-31) — Interest Income: 256000.00
CPT income_statement (quarterly, 2025-12-31) — Interest Income: 100000.00
CPT income_statement (annual, 2025-12-31) — Interest Income Non Operating: 256000.00
CPT income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 100000.00
CPT cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 139625000.00
CPT cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 43695000.00
CPT balance_sheet (annual, 2025-12-31) — Invested Capital: 8263313000.00
CPT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 8263313000.00
CPT cash_flow (annual, 2025-12-31) — Investing Cash Flow: -499539000.00
CPT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -20974000.00